The Valley Desk

NCT05614739 · Interventional trial

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Overall registry status Recruiting

Phase 1

Conditions Neoplasm Metastasis, Ureteral Neoplasms, Urinary Bladder Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov